Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC.

Autor: Le, Xiuning, Nilsson, Monique, Goldman, Jonathan, Reck, Martin, Nakagawa, Kazuhiko, Kato, Terafumi, Ares, Luis Paz, Frimodt-Moller, Bente, Wolff, Katharina, Visseren-Grul, Carla, Heymach, John V., Garon, Edward B.
Zdroj: Journal of Thoracic Oncology; Feb2021, Vol. 16 Issue 2, p205-215, 11p
Databáze: Complementary Index